Devonshire, V. Et Al. 2012. Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study. LANCET NEUROLOGY , vol.11, no.5 , 420-428.

Devonshire, V., Havrdova, E., Radue, E. W., O'Connor, P., Zhang-Auberson, L., Agoropoulou, C., ... Haering, D. A.(2012). Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study. LANCET NEUROLOGY , vol.11, no.5, 420-428.

Devonshire, Virginia Et Al. "Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study," LANCET NEUROLOGY , vol.11, no.5, 420-428, 2012

Devonshire, Virginia Et Al. "Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study." LANCET NEUROLOGY , vol.11, no.5, pp.420-428, 2012

Devonshire, V. Et Al. (2012) . "Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study." LANCET NEUROLOGY , vol.11, no.5, pp.420-428.

@article{article, author={Virginia Devonshire Et Al. }, title={Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study}, journal={LANCET NEUROLOGY}, year=2012, pages={420-428} }